智通财经APP讯,赛生药业(06600)发布公告,于2024年5月22日,根据首次公开发售后购股权计划的规则:根据首次公开发售后购股权计划授出的7500份购股权已失效;及根据首次公开发售后购股权计划授出的4.45万份购股权已获行使。
智通财经APP讯,赛生药业(06600)发布公告,于2024年5月22日,根据首次公开发售后购股权计划的规则:根据首次公开发售后购股权计划授出的7500份购股权已失效;及根据首次公开发售后购股权计划授出的4.45万份购股权已获行使。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.